Emerging Investigators are Pivotal for Meeting Current, Future Drug Development Needs

“We must engage, train and support more physicians as investigators to enable the opportunity for their patients to have access to clinical trials. As an industry, we should be adding anywhere from 10% to 20% new investigators every year to meet the patient access needs for clinical trials.”

There is no question, engaging emerging investigators is vital for meeting current and future drug development needs, but how do we get there? Hear more from Javara’s Tegan Mead, executive director of clinical operations in this recent MedCity News article.

Read More